About 13th Human Amyloid Imaging
The 13th Human Amyloid Imaging will take place in Miami, Florida on January 16-18, 2019.
My co-organizers for the meeting were, once more, Bill Klunk (University of Pittsburgh), Chet Mathis (University of Pittsburgh) and Bill Jagust (University of California, Berkeley).
At HAI 2019 we will continue to emphasize ample lively discussion of core controversies such as: what does the presence of brain amyloid mean, how should it be measured, how does it change, and what does it portend? Our discussions primarily will spring from brief presentations by active investigators who will report unpublished, cutting-edge research in human imaging of amyloid-beta and/or other biomarkers that pertain to Alzheimer’s-related disease.
To assemble HAI, we accept and peer-review only the most recent, important work, abstract submissions. The 2018 meeting drew more than 400 attendees and showcased 130 posters from research groups spanning North America, Europe, East Asia, and Australia.
Research reports are complemented at HAI by Keynote presentations that are intended to cross disciplines and provide perspectives from neuropathology, neurochemistry, psychology, neurology, molecular imaging, clinical trials and biomarker research.
In 2019, we are pleased to welcome two such presentations from Drs. Michel Goedert (University of Cambridge) and John Trojanowski (University of Pennsylvania). In addition to these, we will continue our lectures on basic methods in amyloid PET.
Looking forward to welcoming you to the 13th edition of HAI,
Keith A. Johnson, MD
Massachusetts General Hospital/Harvard Medical School